Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4. (Q36973676)
scientific article published on 10 June 2013
Language:
(P31) (Q13442814)
(P50) (Q6140731)
(Q88137705)
(P304) 1389-1402
(P407) (Q1860)
(P433) 7
(P478) 210
(P577) Monday, June 10, 2013
(P921) (Q1427096)
(P1433) (Q3186912)
(P1476) "Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4." (language: en)
(P2093) Rikke B Holmgaard
Dmitriy Zamarin
David H Munn
(P2860) (Q34319398)
(Q38047057)
(Q35617517)
(Q35753251)
(Q36565695)
(Q28131634)
(Q28740530)
(Q27861062)
(Q33934819)
(Q29619686)
(Q33482453)
(Q37234611)
(Q37322936)
(Q34657284)
(Q39983492)
(Q39989082)
(Q36498459)
(Q38274532)
(Q36286133)
(Q35925641)
(Q36809762)
(Q28283999)
(Q40257073)
(Q40197317)
(Q28259985)
(Q40266751)
(Q34210036)
(Q38317862)
(Q40382287)
(Q34657638)
(Q36219738)
(Q34394487)
(Q35835489)
(Q28246229)
(Q35628246)
(Q28204166)
(Q24679736)
(Q35128003)
(Q34959906)
(Q36376561)
(Q36376598)
(Q28361821)
(Q33937501)
(Q36375152)
(Q28142922)
(Q24336018)
(Q36284594)
(Q36366857)
(Q28275730)
(Q37349845)
(Q42130331)
(Q41808459)
(Q46698119)
(Q43095302)
(Q42051381)
(Q46008329)
(Q46151391)
(Q46178232)
(Q46615195)
(Q45423286)
(Q46490849)
(Q45238898)
(Q45197628)
(Q45047397)
(Q44170968)
(Q44137068)
(Q44135171)
(Q44124436)
(Q56898024)
(Q56902123)
(Q56901877)
(Q79929902)
(Q73567305)
(Q79754960)
other details
description scientific article published on 10 June 2013

External Links